Firms

3E Bioventures Capital

3ebio.com3ebiovc.com

Science-driven venture capital firm investing in biotechnology, TechBio and medical technology. Its published portfolio spans AI medical imaging, neuropsychiatric and neurorestorative therapeutics, condensate biology, targeted protein degradation, gene therapy and precision diagnostics. Named portfolio companies include Subtle Medical, ProNovo Therapeutics, Myrobalan Therapeutics, Neural Galaxy, Dewpoint Therapeutics and Twist Bioscience.

Founded

—

Type

Venture capital

Team

Operations and support

Frank YanPartner

Karen LiuFounding Partner

SHOW MORE

Co-investing

FreeS Fund

• Neural GalaxyCN¥500M · 2021-08-30
• Neural Galaxy$— · 2021-01-07

Lightspeed China Partners

• Neural GalaxyCN¥500M · 2021-08-30
• Neural Galaxy$— · 2021-01-07

AB Magnitude Ventures Group

• Myrobalan Therapeutics$24M · 2024-01-10

ARCH Venture Partners

• Dewpoint Therapeutics$150M · 2022-02-03

BECO Capital

• Dewpoint Therapeutics$150M · 2022-02-03

SHOW MORE

Investments

$—Unknown date	ProNovo Therapeutics	3E Bioventures Capital
$24M2024-01-10	Myrobalan Therapeutics	3E Bioventures Capital, AB Magnitude Ventures Group
$150M2022-02-03	Dewpoint Therapeutics	SoftBank Vision Fund 2, ARCH Venture Partners, Leaps by Bayer, Maverick Ventures, Mirae Asset Capital, General Catalyst, BECO Capital, 3E Bioventures Capital, NS Investment, Polaris Partners, Samsara BioCapital, Mubadala Capital, Elena Viboch, EcoR1 Capital
CN¥500M2021-08-30	Neural Galaxy	3E Bioventures Capital, Lightspeed China Partners, FreeS Fund
$—2021-01-07	Neural Galaxy	Lightspeed China Partners, FreeS Fund, 3E Bioventures Capital
$—Unknown date	Subtle Medical	3E Bioventures Capital
$—Unknown date	Twist Bioscience	3E Bioventures Capital

SHOW MORE